Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 78 (RPL23AP78)

Target: RPL23AP78
Molecular classification: Other (Pseudogene)

Overview

RPL23AP78 is a processed pseudogene located on chromosome 19 (GRCh38: 19:8,728,735-8,729,204, reverse strand)[5]. It is part of a large family of pseudogenes related to the ribosomal protein L23a gene (RPL23A), which encodes a component of the 60S subunit of cytoplasmic ribosomes involved in protein synthesis[6]. RPL23AP78 has no known coding capacity, biological function, disease relevance, or pharmacological importance, and it is not considered a therapeutic target or receptor in biomedical research[1][2][8]. If your intention was to find information about the functional ribosomal protein L23a (gene symbol RPL23A), please note that this is a distinct entity with well-characterized biological roles in ribosome assembly and protein synthesis[6][9][10].

Other names: RPL23A_34_1620RPL23AP78

Mechanism of action

None; no drugs are known to act via this pseudogene[1][2][8]

Biological functions

None established; as a pseudogene, RPL23AP78 is not known to encode a functional protein or serve a defined biological role[1][2][8].

Disease associations

None established; there are no reported associations with disease or drug response for RPL23AP78 specifically[1][2][8]. Note: Some ribosomal protein L23a pseudogenes (such as RPL23AP53) have been investigated for expression changes in cancers, but not RPL23AP78[7].

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 78 (RPL23AP78).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 78 (RPL23AP78).

Explore the full profile